GlassScriptPhysician profile
Lawrence R Whicker
NPI 1891701694
$7,410.67
in general payments reported to CMS, 2019-2025
46 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,893 · 2020: $1,614 · 2021: $1,158 · 2022: $717 · 2023: $715 · 2024: $103 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $866 · Consulting Fee: $150 · Education: $13.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.72 |
| Consulting Fee | $150.00 |
| Education | $13.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,156.81 | 2019-2022 | |
| Biogen, INC. | $1,005.26 | 2019-2023 | Tysabri, Vumerity |
| Novartis Pharmaceuticals Corporation | $779.22 | 2019-2023 | |
| Amgen INC. | $528.22 | 2019-2025 | Uplizna |
| Abbvie INC. | $512.94 | 2019-2024 | Ubrelvy, Qulipta |
| Ucb, INC. | $376.10 | 2019-2024 | Briviact |
| Emd Serono, INC. | $335.70 | 2019-2021 | |
| Ge Healthcare | $309.15 | 2019-2021 | |
| Genzyme Corporation | $286.42 | 2019-2023 | |
| Sunovion Pharmaceuticals INC. | $198.65 | 2019-2022 | |
| Horizon Therapeutics Plc | $189.79 | 2021-2023 | Uplizna |
| Celgene Corporation | $157.60 | 2022-2023 | Zeposia |
| Allergan, INC. | $147.43 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $136.43 | 2019 | |
| Adamas Pharmaceuticals, INC. | $131.62 | 2019-2021 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Whicker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.